查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547125

末梢血管支架植入市场:全球产业分析，规模，占有率，成长，趋势，2024-2033年预测

Peripheral Stent Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球週边血管支架植入物市场的综合报告。该报告全面评估了市场推动因素、趋势、机会、推动因素和挑战等关键市场动态，并提供了有关市场结构的详细见解。

主要的洞察

  • 週边血管支架植入市场规模（2024年）：41亿美元
  • 预估市值（2033 年）：75 亿美元
  • 全球市场成长率（2024 年至 2033 年复合年增长率）：6.9%

週边血管支架植入市场 - 报告范围：

週边血管支架植入物是重要的医疗器械，用于打开心臟以外的周边血管系统（例如腿部和手臂）中狭窄或闭塞的动脉。这些支架可恢復正常的血流并预防肢体缺血等严重併发症。週边血管支架植入物市场的推动因素包括週边动脉疾病（PAD）盛行率的增加、支架技术的进步以及对微创手术的需求不断增加。本报告深入介绍了不同类型的支架，包括裸金属支架、药物洗脱支架和生物可吸收支架，以及它们在不同患者群体中的使用。

推动市场成长的因素：

全球週边血管支架植入物市场受到几个关键因素的推动，例如人口老化、糖尿病和生活方式相关风​​险因素导致 PAD 发病率增加。药物洗脱支架和生物可吸收支架的开发等技术进步正在改善治疗结果并推动市场成长。此外，向恢復时间更短、併发症发生率更低的微创手术的转变正在增加支架植入的采用。旨在促进血管健康的政府措施和医疗保健政策也有助于市场扩张。

市场阻碍因素：

儘管成长前景广阔，但周边血管支架植入市场仍面临与高成本和报销问题相关的挑战。现代支架中使用的先进技术通常会导致价格高昂，这可能成为患者和医疗保健提供者的障碍，特别是在新兴国家。此外，再狭窄和支架内血栓形成等併发症带来了临床挑战，并可能限制市场成长。监管障碍和需要长期临床数据来支持新产品的批准也给市场进入者带来了挑战。

市场机会：

由于持续的研究和开发、人们对血管疾病的认识不断提高以及新兴市场医疗保健基础设施的不断扩大，外周血管支架植入市场提供了巨大的增长机会。开发具有改善的生物相容性、灵活性和药物传输能力的下一代支架有可能改善治疗结果。进入市场的公司可以透过投资创新、与医疗保健提供者建立策略合作伙伴关係以及专注于以患者为中心的产品开发来利用这些机会。个人化医疗的兴起和先进影像技术的采用也为市场成长铺平了道路。

  • 本报告涵盖的主要问题
  • 推动全球週边血管支架植入物市场成长的关键因素是什么？
  • 哪些类型的支架和技术在不同患者群体中处于领先地位？
  • 技术进步如何影响週边血管支架植入物市场的竞争格局？
  • 谁是周边血管支架植入物市场的主要参与者？
  • 全球週边血管支架植入市场的新趋势与未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 蕴藏和除外

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 市场创新/开发趋势

第4章 重要成功要素

  • 各製造厂商的主要的推销策略
  • 主要的法规
  • PESTEL分析
  • 波特分析
  • 产品销售活动
  • 产品的采用/使用情形分析
  • 退还
  • 价值链分析

第5章 市场背景

  • 宏观经济要素
  • 预测要素- 相关性及影响
  • 市场动态

第6章 COVID-19危机分析

  • COVID-19及影响分析
  • 2024年的市场情势

第7章 全球市场规模('000单位)分析

  • 市场规模('000单位)分析，2019～2023年
  • 市场规模('000单位)预测，2024～2033年
    • 与前一年同期比较成长趋势分析

第8章 全球市场- 价格分析

  • 不同材料的各地区价格分析
  • 价格的明细
    • 厂商级的价格设定
    • 分销商级的价格设定
  • 世界平均价格分析基准
  • 价格设定的前提

第9章 全球市场的需求(价值或规模，10亿美元)分析

  • 市场金额(10亿美元)和数量(一千台)分析，2019～2023年
  • 市场规模(10亿美元)和数量(一千台)的分析与预测，市场各分类，2024～2033年
    • 与前一年同期比较成长趋势分析
    • 绝对的商机

第10章 各产品:全球市场分析

  • 简介/主要调查结果
  • 市场规模(10亿美元)和数量(一千台)分析，2019～2023年
  • 市场规模(10亿美元)和数量(一千台)的分析与预测，2024～2033年
    • 裸金属支架 (BMS)
    • 覆膜支架
    • 药物洗脱支架 (DES)
  • 各产品市场魅力分析

第11章 动脉:全球市场分析

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，2019～2023年
  • 市场规模(10亿美元)分析与预测，2024～2033年
    • 颈动脉支架
    • 大腿膝窝动脉动脉支架
    • 髂骨动脉支架
    • 膝窝动脉下动脉支架
  • Artery的市场魅力分析

第12章 各终端用户全球市场分析

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，2019～2023年
  • 市场规模(10亿美元)分析与预测，2024～2033年
    • 医院
    • 门诊病人手术中心/门诊病人
  • 各终端用户市场魅力分析

第13章 各地区全球市场分析

  • 简介/主要调查结果
  • 市场规模(10亿美元)和数量(一千台)分析，2019～2023年
  • 市场规模(10亿美元)和数量(一千台)的分析与预测，2024～2033年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东·非洲
  • 各地区市场的魅力分析

第14章 北美市场分析

第15章 南美市场分析

第16章 欧洲市场分析

第17章 东亚市场分析

第18章 南亚市场分析

第19章 大洋洲市场

第20章 中东·非洲市场分析

第21章 市场结构分析

  • 各级企业市场分析
  • 主要企业的市场占有率分析
  • 市场影响分析

第22章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详细内容
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE &Co. KG
    • Boston Scientific Corporation
    • Cook Medical, Inc.
    • Cardinal Health, Inc.
    • iVascular SLU
    • Medtronic Plc.
    • Terumo Corporation
    • WL Gore &Associates Inc.

第23章 所使用的前提条件与缩写

第24章 调查手法

简介目录
Product Code: PMRREP32225

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral stent implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Peripheral Stent Implants Market Size (2024E): USD 4.1 Bn
  • Projected Market Value (2033F): USD 7.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

Peripheral Stent Implants Market - Report Scope:

Peripheral stent implants are vital medical devices used to open narrowed or blocked arteries in the peripheral vascular system, including the legs, arms, and other areas outside the heart. These stents help restore proper blood flow, preventing severe complications like limb ischemia. The market for peripheral stent implants is driven by the growing prevalence of peripheral artery disease (PAD), advancements in stent technology, and increasing demand for minimally invasive procedures. The report provides insights into various types of stents, such as bare-metal stents, drug-eluting stents, and bioresorbable stents, and their applications across different patient demographics.

Market Growth Drivers:

The global peripheral stent implants market is propelled by several key factors, including the rising incidence of PAD due to an aging population, diabetes, and lifestyle-related risk factors. Technological advancements, such as the development of drug-eluting stents and bioresorbable scaffolds, are enhancing treatment outcomes and driving market growth. Additionally, the shift towards minimally invasive procedures, which offer shorter recovery times and lower complication rates, is increasing the adoption of stent implants. Government initiatives and healthcare policies aimed at improving vascular health also contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the peripheral stent implants market faces challenges related to high costs and reimbursement issues. The advanced technology used in modern stents often leads to higher prices, which can be a barrier for patients and healthcare providers, especially in emerging economies. Additionally, complications such as restenosis and stent thrombosis pose clinical challenges, potentially limiting market growth. Regulatory hurdles and the need for long-term clinical data to support new product approvals also present challenges for market players.

Market Opportunities:

The peripheral stent implants market presents significant growth opportunities driven by ongoing research and development, increasing awareness of vascular diseases, and expanding healthcare infrastructure in emerging markets. The development of next-generation stents with improved biocompatibility, flexibility, and drug-delivery capabilities offers potential for enhanced treatment outcomes. Market players can capitalize on these opportunities by investing in innovation, forming strategic partnerships with healthcare providers, and focusing on patient-centric product development. The growing trend towards personalized medicine and the adoption of advanced imaging technologies also create avenues for market growth.

  • Key Questions Answered in the Report:
  • What are the primary factors driving the growth of the peripheral stent implants market globally?
  • Which types of stents and technologies are leading adoption across different patient demographics?
  • How are technological advancements influencing the competitive landscape of the peripheral stent implants market?
  • Who are the key players contributing to the peripheral stent implants market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global peripheral stent implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral stent implants market, including Boston Scientific Corporation, Abbott Laboratories, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stent solutions, including drug-eluting stents and bioresorbable scaffolds, catering to diverse clinical needs and regulatory standards. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate market access and promote technology adoption. Emphasis on clinical outcomes, patient safety, and cost-effectiveness drives market growth and reinforces the position of key players in the evolving vascular treatment landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Cardinal Health, Inc.
  • iVascular SLU
  • Medtronic Plc.
  • Terumo Corporation
  • W. L. Gore & Associates Inc.

Key Segments Covered in Peripheral Stent Implants Industry Research

Product

  • Bare Metal Stents (BMS)
  • Covered Stents
  • Drug Eluting Stents (DES)

Artery

  • Carotid Artery Stents
  • Fem-Pop Artery Stents
  • Iliac Artery Stents
  • Infrapop Artery Stents

End User

  • Hospitals
  • Ambulatory Surgical Centers/Outpatient

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies, by Manufacturers
  • 4.2. Key Regulations
  • 4.3. PESTEL Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Launch Activities
  • 4.6. Product Adoption/Usage Analysis
  • 4.7. Reimbursement
  • 4.8. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Peripheral Vascular Devices Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. New Product Launches and Approvals
    • 5.2.3. Global Peripheral Vascular Diseases
    • 5.2.4. Research and Development Expenditure by Key Players
    • 5.2.5. Historic and Current Revenue of Key Players
    • 5.2.6. Rising Consumer Awareness of the Product
    • 5.2.7. Rising Adoption of Device Technological Development
    • 5.2.8. Strategic Developments by Key Players
    • 5.2.9. Increasing Adoption of Peripheral Vascular Devices for Various Arteries
    • 5.2.10. Strategic Collaborations among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Artery
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Volume ('000 Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Material
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) and Volume ('000 Units) Analysis, 2019-2023
  • 9.2. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Product, 2024-2033
    • 10.3.1. Bare Metal Stents (BMS)
    • 10.3.2. Covered Stents
    • 10.3.3. Drug Eluting Stents (DES)
  • 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Artery, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Artery, 2024-2033
    • 11.3.1. Carotid Artery Stents
    • 11.3.2. Fem-Pop Artery Stents
    • 11.3.3. Iliac Artery Stents
    • 11.3.4. Infrapop Artery Stents
  • 11.4. Market Attractiveness Analysis by Artery

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers/Outpatients
  • 12.4. Market Attractiveness Analysis by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis Forecast by Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East & Africa
  • 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Artery
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Artery
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Artery
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Artery
        • 14.8.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Artery
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Artery
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Artery
        • 15.8.1.2.3. By End User
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Artery
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Artery
        • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Artery
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Artery
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Artery
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Artery
        • 16.8.2.2.3. By End User
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Artery
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Artery
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Artery
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Artery
        • 16.8.6.2.3. By End User
    • 16.8.7. Russia Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Artery
        • 16.8.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Artery
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Artery
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Artery
        • 17.8.1.2.3. By End User
    • 17.8.2. Japan Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Artery
        • 17.8.2.2.3. By End User
    • 17.8.3. South Korea Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Artery
        • 17.8.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Artery
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Artery
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Artery
        • 18.8.1.2.3. By End User
    • 18.8.2. Indonesia Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Artery
        • 18.8.2.2.3. By End User
    • 18.8.3. Malaysia Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Artery
        • 18.8.3.2.3. By End User
    • 18.8.4. Thailand Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Artery
        • 18.8.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Artery
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Artery
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Artery
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Artery
        • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Artery
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Artery
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Artery
        • 20.8.1.2.3. By End User
      • 20.8.1.3. Turkiye Market Analysis
      • 20.8.1.4. Introduction
      • 20.8.1.5. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.5.1. By Product
        • 20.8.1.5.2. By Artery
        • 20.8.1.5.3. By End User
    • 20.8.2. South Africa Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Artery
        • 20.8.2.2.3. By End User
    • 20.8.3. North Africa Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Artery
        • 20.8.3.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Abbott Laboratories
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Key Developments
      • 22.3.1.7. Strategy Overview
        • 22.3.1.7.1. Marketing Strategy
        • 22.3.1.7.2. Product Strategy
        • 22.3.1.7.3. Channel Strategy
    • 22.3.2. B. Braun Melsungen AG
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Key Developments
      • 22.3.2.7. Strategy Overview
        • 22.3.2.7.1. Marketing Strategy
        • 22.3.2.7.2. Product Strategy
        • 22.3.2.7.3. Channel Strategy
    • 22.3.3. Biotronik SE & Co. KG
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Key Developments
      • 22.3.3.7. Strategy Overview
        • 22.3.3.7.1. Marketing Strategy
        • 22.3.3.7.2. Product Strategy
        • 22.3.3.7.3. Channel Strategy
    • 22.3.4. Boston Scientific Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Key Developments
      • 22.3.4.7. Strategy Overview
        • 22.3.4.7.1. Marketing Strategy
        • 22.3.4.7.2. Product Strategy
        • 22.3.4.7.3. Channel Strategy
    • 22.3.5. Cook Medical, Inc.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Key Developments
      • 22.3.5.7. Strategy Overview
        • 22.3.5.7.1. Marketing Strategy
        • 22.3.5.7.2. Product Strategy
        • 22.3.5.7.3. Channel Strategy
    • 22.3.6. Cardinal Health, Inc.
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Key Developments
      • 22.3.6.7. Strategy Overview
        • 22.3.6.7.1. Marketing Strategy
        • 22.3.6.7.2. Product Strategy
        • 22.3.6.7.3. Channel Strategy
    • 22.3.7. iVascular SLU
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Key Developments
      • 22.3.7.7. Strategy Overview
        • 22.3.7.7.1. Marketing Strategy
        • 22.3.7.7.2. Product Strategy
        • 22.3.7.7.3. Channel Strategy
    • 22.3.8. Medtronic Plc.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Key Developments
      • 22.3.8.7. Strategy Overview
        • 22.3.8.7.1. Marketing Strategy
        • 22.3.8.7.2. Product Strategy
        • 22.3.8.7.3. Channel Strategy
    • 22.3.9. Terumo Corporation
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Key Developments
      • 22.3.9.7. Strategy Overview
        • 22.3.9.7.1. Marketing Strategy
        • 22.3.9.7.2. Product Strategy
        • 22.3.9.7.3. Channel Strategy
    • 22.3.10. W. L. Gore & Associates Inc.
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Key Developments
      • 22.3.10.7. Strategy Overview
        • 22.3.10.7.1. Marketing Strategy
        • 22.3.10.7.2. Product Strategy
        • 22.3.10.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology